CAPTAIN T CELL
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
CAPTAIN T CELL
Industry:
Health Care Therapeutics Wellness
Address:
Berlin, Berlin, Germany
Country:
Germany
Status:
Active
Current Employees Featured
More informations about "Captain T Cell"
Charles River and Captain T Cell Announce Manufacturing Alliance
As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract development and …See details»
Captain T Cell - Crunchbase Company Profile & Funding
Captain T Cell may be growing as evidenced by the recent announcement of a manufacturing alliance with Charles River for gene-modified therapies. This …See details»
NEWS - captaintcell.com
Schoenefeld/Berlin, Germany, May 22, 2024 — Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, today announced the successful …See details»
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Jun 25, 2024 Charles River Laboratories International, Inc. CRL and Captain T Cell, a spinoff from Max Delbrück Center in Germany, entered into an agreement on plasmid DNA and …See details»
Captain T Cell - LinkedIn
Captain T Cell | 596 followers on LinkedIn. Off-the-shelf T cells for solid tumor patients | Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that ...See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
Jun 17, 2024 As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract …See details»
Captain T Cell GmbH - VentureRadar
"Captain T Cell GmbH is a biotechnology company that focuses on developing next-generation T cells against solid tumors. The firm's first-in-class lead program and novel allogeneic platform …See details»
Captain T Cell - Funding, Financials, Valuation & Investors
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.See details»
Captain T Cell 2025 Company Profile: Valuation, …
Jan 1, 2018 Information on valuation, funding, cap tables, investors, and executives for Captain T Cell. Use the PitchBook Platform to explore the full profile.See details»
Charles River and Captain T Cell Announce Plasmid DNA and
Jun 17, 2024 About Captain T Cell Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that are not addressed by existing treatments. Captain T …See details»
Charles River and Captain T Cell Form Alliance for Gene Therapy ...
Jun 24, 2024 The agreement will provide Captain T Cell with access to Charles River’s extensive CDMO (Contract Development and Manufacturing Organization) capabilities and advisory …See details»
Charles River and Captain T Cell Join Forces to Advance
Jun 17, 2024 Under this alliance, Captain T Cell will gain access to Charles River's Cell and Gene Therapy (CGT) Accelerator Program (CAP), which provides an array of cutting-edge …See details»
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Jun 18, 2024 Charles River Laboratories International, Inc. CRL and Captain T Cell, a spinoff from Max Delbrück Center in Germany, entered into an agreement on plasmid DNA and …See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
Jun 17, 2024 As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Captain T Cell will have access to established plasmid and viral vector contract …See details»
Charles River and Captain T Cell Announce Plasmid DNA and Viral …
Jun 17, 2024 Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, todaySee details»
Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector ...
Jun 17, 2024 Charles River Laboratories International Inc. and Captain T Cell, a spinoff from the Max Delbrück Center Berlin, Germany, have signed a plasmid DNA and retrovirus vector …See details»
Captain T Cell Secures Seed Financing
May 22, 2024 About Captain T Cell Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that are not addressed by existing treatments. Captain T …See details»
Captain T Cell Secures Seed Financing Round Totaling € 8.5 ... - i&i …
May 22, 2024 Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, today announced the successful closing of a seed financing round …See details»
Captain T Cell Secures $8.5M Seed Funding to Advance …
Captain T Cell, a groundbreaking biotech company based in Germany, announced the successful completion of their latest funding round, raising an impressive $8,500,000. The company …See details»
Captain T Cell - Contacts, Employees, Board Members
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.See details»